Cargando…

Mechanisms and insights into drug resistance in cancer

Cancer drug resistance continues to be a major impediment in medical oncology. Clinically, resistance can arise prior to or as a result of cancer therapy. In this review, we discuss different mechanisms adapted by cancerous cells to resist treatment, including alteration in drug transport and metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zahreddine, Hiba, Borden, Katherine L. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596793/ https://www.ncbi.nlm.nih.gov/pubmed/23504227 http://dx.doi.org/10.3389/fphar.2013.00028

Ejemplares similares

Sonic Hedgehog factor Gli1: As good as resistant
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2015)

Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
por: Xu, Yishi, et al.
Publicado: (2023)

Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites
por: El-Readi, Mahmoud Zaki, et al.
Publicado: (2021)

Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
por: Lu, Jiabin, et al.
Publicado: (2021)

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
por: Tamburrino, Anna, et al.
Publicado: (2013)

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
por: Wu, Xiaofan, et al.
Publicado: (2022)

The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma
por: Lu, Enzhou, et al.
Publicado: (2022)

Editorial: Insights in pharmacology of anti‐cancer drugs: 2021
por: Sancho, Patricia, et al.
Publicado: (2022)

Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1
por: Zhang, Hao, et al.
Publicado: (2022)

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
por: Zhou, Jiabei, et al.
Publicado: (2020)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

Combating and overcoming drug resistance in cancer
por: Price, Douglas K.
Publicado: (2014)

The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
por: Rezaee, Malihe, et al.
Publicado: (2023)

Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023)

A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells
por: Han, Yu, et al.
Publicado: (2019)

Antibacterial Activity and Mechanism of Action of Aspidinol Against Multi-Drug-Resistant Methicillin-Resistant Staphylococcus aureus
por: Hua, Xin, et al.
Publicado: (2018)

FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
por: Wang, Wanqing, et al.
Publicado: (2023)

Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
por: Zhang, Hai-Bo, et al.
Publicado: (2023)

Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative
por: González, María L., et al.
Publicado: (2017)

Editorial: Insights in drug metabolism and transport: 2021
por: Piñeiro-Llanes, Janny, et al.
Publicado: (2023)

The Breast Cancer Stem Cells Traits and Drug Resistance
por: Zheng, Qinghui, et al.
Publicado: (2021)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Insights Into the Resistance Mechanisms of Inhibitors to FLT3 F691L Mutation via an Integrated Computational Approach
por: Sun, Yunfeng, et al.
Publicado: (2019)

Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids
por: Tilaoui, Mounir, et al.
Publicado: (2021)

Levofloxacin: Insights Into Antibiotic Resistance and Product Quality
por: Izadi, Ensieh, et al.
Publicado: (2019)

COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma
por: Liu, Zongheng, et al.
Publicado: (2022)

The sonic hedgehog factor Gli1 imparts drug resistance through inducible glucuronidation
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2014)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

Insight Into the Mechanism of Exercise Preconditioning in Ischemic Stroke
por: Zhu, Yuanhan, et al.
Publicado: (2022)

Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
por: Xiao, Huan, et al.
Publicado: (2021)

Editorial: Phytochemical-based nanoformulations to tackle drug resistance in cancer
por: Tuli, Hardeep Singh, et al.
Publicado: (2023)

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology
por: Guo, Pengfei, et al.
Publicado: (2019)

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
por: Yao, Jingwei, et al.
Publicado: (2020)

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
por: Kim, Seong Keun, et al.
Publicado: (2022)

PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies
por: Wang, Nannan, et al.
Publicado: (2022)

From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib
por: Abdel-Aziz, Amal Kamal, et al.
Publicado: (2017)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

In Silico Prediction and Insights Into the Structural Basis of Drug Induced Nephrotoxicity
por: Shi, Yinping, et al.
Publicado: (2022)

Structural Insights Into the High Selectivity of the Anti-Diabetic Drug Mitiglinide
por: Wang, Mengmeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nb5gsh1ub430dke6pa3ar7bena